Page 317 - Medicare Benefit Policy Manual

Rev # Issue Date Subject Impl Date CR#
Medically-Accepted Indications for
Off-Label Uses of Drugs and
Biologicals in an Anti-Cancer
Chemotherapeutic Regimen

R80BP 01/11/2008 Requirements for Ordering and 11/19/2007 5743
Following Orders for Diagnostic
Tests – Replaced by Transmittal 80

R79BP 10/19/2007 Requirements for Ordering and 11/19/2007 5743
Following Orders for Diagnostic
Tests – Replaced by Transmittal 80

R78BP 09/21/2007 Unlabeled Use for Anti-Cancer 10/22/2007 5729
Drugs – Medical Literature Used to
Determine Medically Accepted
Indications for Drugs and
Biologicals Used in Anti-Cancer
Treatment

R77BP 08/29/2007 Testing and Implementation of 01/07/2008 5680
2008 Ambulatory Surgical Center
(ASC) Payment System Changes

R76BP 07/20/2007 Testing and Implementation of 01/07/2008 5680
2008 Ambulatory Surgical Center
(ASC) Payment System Changes –
Replaced by Transmittal 77

R75BP 08/17/2007 Nurse Practitioner (NP) Services 11/19/2007 5639
and Clinical Nurse Specialist
(CNS) Services

R74BP 06/29/2007 Medicare Telehealth Services 01/07/2008 5628

R72BP 05/25/2007 Guidelines for Payment of Diabetes 07/02/2007 5433
Self-Management Training
(DSMT)

R71BP 05/25/2007 Clarification of Manual Instruction 07/02/2007 5536
Regarding the Scope of Portable X-
Ray Benefit

R70BP 05/11/2007 Bone Mass Measurements (BMMs) 07/02/2007 5521